Bayesian Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $339K | Buy |
|
|||||
2024
Q4 | – | Sell |
|
|||||
2024
Q3 | $324K | Sell |
|
|||||
2024
Q2 | $433K | Buy |
|
|||||
2023
Q1 | – | Sell |
|
|||||
2022
Q4 | $562K | Buy |
|
|||||
2022
Q3 | $262K | Buy |
|
|||||
2022
Q2 | – | Sell |
|
|||||
2022
Q1 | $486K | Buy |
|
|||||
2021
Q3 | – | Sell |
|
|||||
2021
Q2 | $500K | Buy |
|
|||||
2020
Q3 | – | Sell |
|
|||||
2020
Q2 | $510K | Buy |
|
|||||
2020
Q1 | $439K | Sell |
|
|||||
2019
Q4 | $885K | Buy |
|
|||||
2019
Q3 | $441K | Buy |
|
|||||
2019
Q1 | – | Sell |
|
|||||
2018
Q4 | $726K | Buy |
|
|||||
2018
Q3 | $499K | Sell |
|
|||||
2018
Q2 | $1.31M | Buy |
|
|||||
2018
Q1 | $658K | Sell |
|
|||||
2017
Q4 | $738K | Buy |
|
|||||
2017
Q1 | – | Sell |
|
|||||
2016
Q4 | $403K | Buy |
|